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During birth in mammals, a pronounced surge of fetal peripheral
stress hormones takes place to promote survival in the transition to
the extrauterine environment. However, it is not known whether the
hormonal signaling involves central pathways with direct protective
effects on the perinatal brain. Here, we show that arginine vasopres-
sin specifically activates interneurons to suppress spontaneous net-
work events in the perinatal hippocampus. Experiments done on the
altricial rat and precocial guinea pig neonate demonstrated that the
effect of vasopressin is not dependent on the level of maturation
(depolarizing vs. hyperpolarizing) of postsynaptic GABAA recep-
tor actions. Thus, the fetal mammalian brain is equipped with an
evolutionarily conserved mechanism well-suited to suppress en-
ergetically expensive correlated network events under condi-
tions of reduced oxygen supply at birth.
KCC2 | bumetanide | oxytocin | birth asphyxia | GDP
In mammalian development, birth is an abrupt transitory stage,where dramatic physiological changes occur in all organ systems
of the fetus to facilitate the adaptation of the neonate to extra-
uterine conditions (1). A major challenge for the brain, which
relies on oxidative metabolism, is the period of obligatory asphyxia
that is associated with the transition from umbilical to lung-based
exchange of oxygen and carbon dioxide. In humans, various situ-
ations where this transition is protracted lead to pathophysiolog-
ical perinatal asphyxia, with an annual global death rate of 4 million
neonates (2) and a wide spectrum of psychiatric and neurological
disorders among the survivors (3), underscoring the importance of
studies on the basic physiological mechanisms that have evolved to
protect the brain at and around birth. In the face of an energy
metabolic crisis caused by lack of oxygen at birth, an obvious
adaptive strategy to protect the brain is to suppress neuronal
activity, especially in regions such as the neocortex and hip-
pocampus, which are particularly sensitive to hypoxia.
Birth coincides with an exceptionally prominent activation of
the fetal hypothalamus–pituitary–adrenal (HPA) axis, which
plays a key role in adjusting cardiorespiratory, metabolic, and
thermoregulatory functions, promoting the neonate’s survival
and protection of vulnerable organs against trauma during par-
turition (1, 4–9). Increased central drive of the fetal HPA axis at
the level of both corticotropic and arginine vasopressin (AVP)
signaling has been reported in late mammalian gestation and
delivery (10). AVP, mainly derived from neurons located in the
fetal hypothalamic supraoptic (SON) and paraventricular (PVN)
nuclei (11, 12), is one of the key mediators of the birth-related
adaptive stress responses (9, 10, 13, 14). During delivery, AVP
secretion from the hypothalamic nuclei into the fetal circulation
via the posterior pituitary is massively elevated (13–18). In sheep
and humans (19–21), this parturition-related AVP surge has
been shown to take place both in the blood and cerebrospinal
fluid, further suggesting that central and peripheral vasopressinergic
pathways are activated in parallel at birth. In the present context, it is
of particular interest that hypoxia is an effective trigger of AVP re-
lease (13, 14, 18, 22), and that experimental neonatal asphyxia in the
rat activates neurons in the PVN (23), which have central projec-
tions. It has been shown that in mature rodents, vasopressinergic
fibers from the hypothalamus, particularly from the PVN, proj-
ect to several limbic structures, including the entorhinal cortex,
amygdala, and hippocampus (24–26), but such information on
the perinatal brain is scarce (27). Finally, activation of V1a AVP
receptors (V1aRs) has been shown to exert neuroprotective and
antiinflammatory actions on neocortical and hippocampal neu-
rons (28, 29).
As a whole, the above structural and functional data lay a
promising foundation for a close examination of the possible
perinatal actions of AVP in vulnerable neuronal networks.
However, a challenge for studies on protective mechanisms is
brought by the very different maturational level of the brain in
distinct mammalian species at birth. For instance, the developmental
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shift from depolarizing to hyperpolarizing GABAA receptor
(GABAAR)-mediated responses takes place postnatally in the rat
but occurs already in the early fetal period in guinea pigs (30). A
general mammalian neuroprotective mechanism at birth should be
independent of whether GABA is depolarizing (i.e., rats) or hyper-
polarizing (i.e., guinea pigs) in the neonate’s brain.
In the present work, we provide evidence of powerful sup-
pression of hippocampal spontaneous network events by AVP
during the perinatal period. Our data show that at birth, the rat
hippocampus is already innervated by vasopressinergic fibers.
AVP at nanomolar concentrations leads to a V1aR-mediated
transient suppression of spontaneous neuronal network activity
in the perinatal hippocampus of both the altricial rat and the
precocial guinea pig, independent of the maturational level of
the GABAergic system. This suppression is caused by activation
of CA3 stratum lucidum-radiatum (SLR) interneurons, leading
to a decrease in the synchronous GABAergic activity that is
needed for the sculpting of spontaneous network events paced by
intrinsically bursting glutamatergic CA3 neurons (31–33). In
sum, our work demonstrates a fast-acting mechanism whereby
centrally released AVP is poised via suppression of energetically
costly temporal overlap between GABAergic and glutamatergic
synaptic inputs (34) to protect the perinatal brain during birth.
Results
Vasopressinergic Innervation of the Rat Hippocampus at Birth.While
vasopressinergic innervation of the hippocampus has been dem-
onstrated in adult rats (26), there are practically no structural data
of this kind available for the newborn rat (27). Therefore, we
combined the whole-tissue clearing method CLARITY (35) with
immunostaining against neurophysin II (NPII; the AVP carrier
protein) to specifically label vasopressinergic cells and projections
(36). NPII-positive cell bodies were clearly seen in the PVN, SON,
and accessory nuclei of the hypothalamus (Fig. 1 A1 and A2). In all
samples, we detected segments of NPII-positive fibers scattered
across the hippocampal formation (Fig. 1 B1 and B2, Fig. S1, and
Movie S1). The NPII-positive fibers often appeared to be enriched
in the vicinity of the hippocampal fissure, alveus, and fimbria. In
addition, numerous NPII-positive fibers were detected in various
parts of the limbic system, including the amygdala. These data
indicate that the rat hippocampus receives vasopressinergic in-
nervation at birth.
GABA Is Depolarizing Throughout the Perinatal Period. AVP is
known to have a direct effect on a variety of neuronal pop-
ulations (37). In the immature rat hippocampus in vitro, giant
depolarizing potentials (GDPs), driven by depolarizing actions
of GABA, represent the most prominent type of spontaneous
network activity pattern (38). Thus, our next question was
whether vasopressinergic signaling could modulate this early
network activity at around birth. However, the depolarizing
GABAAR-mediated drive that GDPs depend on (31, 38, 39)
has been suggested to be transiently abolished around birth by
functional down-regulation of NKCC1 (40, 41). Hence, we first
examined whether the NKCC1-dependent GDPs are present
throughout the perinatal period [from embryonic day (E)
21.5 to postnatal day (P) 2]. Field GDPs (fGDPs), recorded
from the CA3 region in the in toto hippocampal preparation
(42), were reliably observed not only at P0 and later postnatal age
points as described before (31, 39) but, in fact, throughout the
perinatal period (Fig. 2 A and B). Notably, at all age points ex-
amined, fGDPs were completely blocked by the NKCC1 inhibitor
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Fig. 1. Hippocampus of P0 rats receives vasopressinergic innervation. (A1) Overview of a whole P0 rat brain optically cleared using CLARITY and stained
against NPII (n = 2 within 2 h from birth and n = 3 during later time points at P0). Grid squares are 2 × 2 mm in size. (A2) Rectangle in A1 is shown at higher
magnification. NPII staining strongly labels the vasopressinergic cell bodies in the hypothalamic area. The PVN are visible on the left side of the image, and the
SON are visible in the upper right corner. 3V, third ventricle. (Scale bar: 200 μm.) (B1) NPII-positive fibers were detected in various parts of the hippocampal
formation, including CA3 and the dentate gyrus (DG). (Scale bar: 200 μm.) (B2) Magnification of the rectangle shown in B1 depicts a segment of a single NPII-
positive fiber in the CA3 region. (Scale bar: 50 μm.) An overview of NPII-positive fibers throughout the hippocampus is shown in Movie S1.
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bumetanide (10 μM), indicating that GABA is depolarizing in the
intact perinatal rat hippocampus.
To confirm that the perinatal excitatory GABA actions are
present at the cellular level, we used both noninvasive loose cell-
attached recordings and Ca2+ imaging in visually identified
CA3 pyramidal neurons (Fig. 2 C and D). Puff-application of the
selective GABAAR agonist isoguvacine (100 μM) elicited spiking
in ∼95% of neurons (137 of 143 neurons) between E21.5 and
P1 in the presence of ionotropic glutamate receptor (iGluR)
blockers (Materials and Methods and Fig. 2C). The isoguvacine-
evoked spiking was fully blocked by bumetanide. Here, we would
like to point out that these experiments are not intended to
address the question of whether GABAAR actions would directly
evoke spikes in vivo (43, 44), but they do indicate that the re-
versal potential of GABAAR-mediated current (EGABA) is
maintained by NKCC1-dependent Cl− accumulation at a level
more positive than the resting membrane potential. In agreement
with the above observations, Ca2+ imaging done in CA3 pyramidal
neurons from slices collected within 2 h after birth and during later
time points at P0 showed that GABAAR activation (with either
GABA or muscimol) evoked substantial intracellular Ca2+ tran-
sients in virtually all (195 of 197) cells (Fig. 2D). These Ca2+ tran-
sients were blocked by a combination of nifedipine (10 μM) and
Ni2+ (100 μM), which act as antagonists of L- and T-type Ca2+
channels, respectively. Together, these results indicate that in
hippocampal CA3 pyramidal neurons, GABA is depolarizing
throughout the perinatal period.
AVP Suppresses Perinatal fGDPs via V1aRs. After confirming the
presence of network activity driven by depolarizing GABA in the
perinatal rat hippocampus, we moved on to test how it is affected by
exogenous AVP. At 10 nM, AVP had a robust suppressing action
on fGDPs recorded from the in toto rat hippocampus throughout
the perinatal period (Fig. 3A and Fig. S2 A and B). This suppression
was both qualitatively and quantitatively similar in hippocampal
slices (Fig. S2B). In both preparations, the AVP-mediated sup-
pression of fGDPs was transient, which is readily explained by re-
ceptor desensitization (45). Recovery from desensitization was near
complete after 10 min of AVP washout as seen in experiments with
two consecutive applications (Fig. S2C).
Central neurons are known to express V1aRs, V1bRs, and
oxytocin receptors (OTRs) (37), and AVP is a potent ligand for
each of them (46). Importantly, we found that the suppression of
fGDPs by AVP was largely prevented by SR49059, a competitive
antagonist (47) of V1aRs (Fig. 3B). At 20 nM, SR49059 is se-
lective for V1aRs (Ki = 2.2 nM for V1aRs, Ki = 671 nM for
V1bRs, and Ki = 76 nM for OTRs). As might be expected on the
basis of the competitive nature of SR49059, the block of the
action of AVP was not complete. Notably, however, SR49059
(20 nM) by itself did not affect fGDPs (Fig. S3). Since AVP has
an almost equal affinity for V1aRs and OTRs in the rat (Ki at
V1aR = 2.6 nM vs. Ki at OTR = 1.7 nM) (46), we tested whether
OTRs play any role in the AVP-induced suppression of fGDPs.
Unlike AVP, 10 nM oxytocin (OT) had no discernible effect on
fGDPs (Fig. 3C). Given that the OT Kis for OTRs and V1aRs
200 s
PNH2E21.5
E2
1.5
PN
H2 P0 P1
C
el
ls
 e
xc
ite
d 
by
 Is
og
 (%
)
0
50
100
+ Bume 
1 s
40 pA
Isog  
Isog 12
/1
3
16
/1
7
35
/3
6
74
/7
7
R
el
at
iv
e 
in
cr
ea
se
 in
 Δ
F/
F  
1.0
1.1
1.2
GABA 
+Nifedipine 
+Ni2+ 
50 s
ΔF/F 20% Con
trol
Nif
edi
pin
e
+ N
i2+  
P<0.001
93
PN
H2 P0C
el
ls
 re
sp
on
di
ng
 to
 
G
A
B
A
A
R
 a
go
ni
st
 (%
)
0
50
100
68
/6
9
12
7/
12
8
Bume  Bume  
10 s
10 μV 
GABA 
PN
H2
-P1
+B
um
e
0/
20
A B
C D
Fig. 2. GABA is depolarizing throughout the perinatal period in rat CA3 pyramidal neurons. Sample traces of fGDPs from the CA3 region of E21.5 (A) and
PNH2 (B) in toto hippocampi (filtered at 1–10 Hz). Bumetanide (Bume, 10 μM) fully blocked fGDPs in all recordings (E21.5, n = 3; PNH2, n = 5). (Insets)
Magnified views. (Scale bar values in B apply also to A.) (C) Puff-application of isoguvacine (Isog, 100 μM) elicits spiking in perinatal CA3 pyramidal neurons in
the presence of iGluR block. Evoked spikes were abolished by bath application of Bume. Sample traces from a loose patch recording (Left) and the percentage
of cells responding to Isog in all perinatal age groups (Right) are shown. (D, Left) Representative sample traces showing intracellular calcium [Ca2+]i transients
evoked by GABA (75 μM) in the absence and presence of the L- and T-type Ca2+ channel inhibitors nifedipine (10 μM) and Ni2+ (100 μM) in Fluo4-loaded
CA3 pyramidal neurons. (D, Center) Percentages of cells responding to GABAAR activation with an increase in [Ca
2+]i at PNH2 and P0 . (D, Right) Mean re-
duction of [Ca2+]i transients upon activation of GABAARs before and during L- and T-type Ca
2+ channel inhibition (pooled data from PNH2, n = 19; P0, n = 20;
paired t test was used for statistical analysis). Data are provided as mean ± SEM, and n values are provided in bars. ΔF/F, fluorescence change divided by
baseline fluorescence.
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are 1.0 nM and 71 nM (46), respectively, the above observations
show that the suppression of perinatal fGDPs by nanomolar
AVP concentrations is mediated by V1aRs, with no involvement
of OTRs.
GABAergic Input onto Pyramidal Neurons Is Increased by AVP.As the
synchronous activation of both pyramidal neurons and interneu-
rons has been shown to be crucial for the generation of fGDPs (31,
39), alterations in the excitability of either of these cell types could
underlie the observed effect of AVP. Multiple-unit activity recor-
ded extracellularly in CA3 stratum pyramidale (SP) in the presence
of iGluR block and picrotoxin was not altered by application of
AVP (Fig. S4A). Furthermore, neither pyramidal neuron spon-
taneous excitatory postsynaptic currents (sEPSCs) nor intrinsic
properties (voltage-clamp recordings of holding current and current-
clamp recordings of input resistance) were affected by AVP (Fig. S4
B–D). Together, these data show that the suppression of fGDPs
by AVP is not mediated by direct modulation of the excitability
of CA3 pyramidal neurons. Hence, we shifted our focus onto
CA3 interneurons.
We recorded spontaneous inhibitory postsynaptic currents
(sIPSCs) from pyramidal neurons in the presence of iGluR block.
Strikingly, AVP (10 nM) increased the frequency of sIPSCs by
about a factor of 2 (Fig. 4A). This increase was strongly attenuated
in the presence of SR49059 (20 nM). In line with the effect of this
antagonist in fGDP experiments (Fig. 3B), a small yet significant
increase remained (Fig. 4A). The increase of sIPSC frequency
was not markedly potentiated by using higher concentrations
of AVP (Fig. 4B). Neither the amplitude of sIPSCs nor the
frequency and amplitude of tetrodotoxin (TTX)-insensitive
miniature IPSCs (mIPSCs) were affected by AVP (Fig. S5).
Importantly, AVP had no effect on the driving force of
GABAAR-mediated currents in pyramidal neurons, as assessed
in gramicidin-perforated patch recordings (Fig. S6). In conclu-
sion, our data show that the increase in sIPSC frequency was due
to increased spiking of interneurons and AVP did not affect
pyramidal neuron properties.
AVP Specifically Activates SLR Interneurons via V1aRs. Next, we
performed whole-cell current-clamp recordings from visually
identified GABAergic interneurons in slices from P0–P2 VGAT-
Venus rats (48) in the presence of iGluR block and picrotoxin
(Fig. 4 C–E and Fig. S7). Upon application of AVP, the mem-
brane potential of CA3 SLR interneurons depolarized by 4 ±
0.85 mV from a resting level of −59.9 ± 1.2 mV (n = 7), leading
to a consequent increase in their spike frequency. Both the de-
polarization and the subsequent increase in the spike rate were
prevented by SR49059 (Fig. 4 C–E). Notably, interneurons lo-
cated in CA3 stratum oriens (SO) and SP did not respond to
AVP (Fig. 4 D and E and Fig. S7).
To examine the expression of V1aRs in the CA3 area of the
P0 rat hippocampus, we used the highly sensitive fluorescent in
situ RNAscope assay (49). In agreement with our electrophysi-
ological data, V1aR mRNA was detected in the SLR, where it
localized to a subset of Gad1- and Gad2-positive interneurons
(Fig. 4 F and G). In contrast, V1aR expression was low in SP and
not detectable in SO. We did not detect V1bR mRNA in the
P0 hippocampus (Fig. 4 F and G, a positive control is shown in
Fig. S8). In conclusion, our data show that AVP specifically ac-
tivates SLR interneurons via V1aRs in the CA3 area of the
perinatal hippocampus.
AVP Suppresses fGDPs by Decreasing Synchronous GABAergic Drive.
The synchronous activity of interneurons, promoting a depola-
rizing and excitatory GABAergic drive upon glutamatergic
CA3 pyramidal neurons, plays a crucial role in the generation
and temporal patterning of fGDPs (31, 33, 50). Therefore, tonic
firing of interneurons, such as that triggered by AVP, is expected
to interfere with the role of GABAergic signaling in network
synchronization, thereby suppressing the fGDPs. To test this, we
performed triple-electrode recordings with intracellular current-
and voltage-clamp recordings from two CA3 pyramidal neurons
(∼100–200 μm apart) and a local field potential (LFP) electrode
in the SP to monitor fGDPs (Fig. 5A). As is evident in the speci-
men recording, the robust and stable patterns of depolarization
and firing of the pyramidal neurons (intracellular GDPs) were
disrupted in the presence of AVP, which is in full agreement with
the suppression of their extracellular network level counterparts,
the fGDPs (Fig. 5B). In more quantitative terms, the rate of py-
ramidal spiking during GDPs was dramatically decreased by AVP
(Fig. 5C). This decrease in “GDP-nested” spiking is not attribut-
able to a general change in pyramidal neuron excitability (also Fig.
S4), as the pyramidal neurons’ inter-GDP spike rates remained
unaffected by AVP (Fig. 5C). Moreover, GDP-associated syn-
chronous GABAergic drive onto pyramidal neurons, as quantified
by sIPSC burst area, was suppressed to about 50% from baseline
levels (Fig. 5D). Additionally, the AVP-induced effects on sIPSC
frequency and sIPSC burst total area displayed strikingly similar
time courses (Fig. 5D). Together, these data support the idea
that the loss of the synchronous excitatory drive of interneurons is
the underlying mechanism by which AVP suppresses fGDPs in the
neonatal rat hippocampus.
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Fig. 3. AVP suppresses hippocampal fGDPs in a V1aR-dependent manner
during the perinatal period. (A–C, Left) Sample traces of fGDPs measured
from the hippocampal CA3 region (filtered at 1–10 Hz). (A–C, Center) Con-
tinuous quantification of the mean normalized fGDP total area throughout
the experiment; data are shown as a moving average (60-s window, 10-s
bins, 10-s step) ± SEM. (A–C, Right) Quantification of the neurohormone
effect on the mean normalized fGDP total area (mean ± SEM). Here and in
the following figures, we quantified the (average) values during minutes
2 to 4 from the start of AVP application. (A) Effect of AVP (10 nM) on fGDPs
in E21.5 and PNH2–P1 in toto hippocampi. (B) AVP application in the con-
tinuous presence of the V1aR antagonist SR49059 in P0–P1 hippocampal
slices. (C) fGDPs in P0–P1 slices before and during bath application of OT
(10 nM). The n values are provided in the panels. A paired t test was used for
statistical analysis. (Scale bar values in C apply to all sample traces.)
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Suppression of Hippocampal Network Events by AVP Does Not
Depend on the Level of Maturation of Neuronal Cl− Extrusion. To
study whether the desynchronizing action of AVP on hippocampal
network events is dependent on the stage of maturation of Cl− ex-
trusion, we employed the guinea pig, a precocial species, whose
young are born at a much more mature stage of cortical devel-
opment (51). In contrast to the rat, guinea pig hippocampal pyra-
midal neurons express high levels of transport-functional KCC2 and
generate robust hyperpolarizing GABAAR responses already by
birth (30). In agreement with this, whole-cell recordings with a high
somatic Cl− load imposed via the patch pipette demonstrated ro-
bust KCC2-mediated Cl− extrusion capacity in P0 guinea pig
CA3 pyramidal neurons, similar to that seen in juvenile P16 rats
(Fig. 6A1–3). In contrast, active Cl
− extrusion was virtually absent in
both newborn rats and midgestation guinea pig embryos (Fig. 6A3).
The temporal expression patterns of KCC2 protein in the rat and
guinea pig hippocampus (Fig. 6B) fully complemented the results
obtained in the measurements of Cl− extrusion capacity, which is in
line with the difference in the timing of brain development relative
to birth in these two species (51).
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presence (Bottom) of SR49059 are shown. (D) Depolarization of interneurons from SLR (in the absence or presence of SR49059), SO, and SP upon application
of AVP. (E, Left) Continuous quantification of the mean spike rate of SLR interneurons before and during bath application of AVP. (E, Right) Comparison of
spike rates (control vs. peak effect of AVP) of interneurons from SLR (in the absence or presence of SR49059), SO, and SP before and during application of
AVP. Data are presented as mean ± SEM, and n values are provided in the figure. Paired and independent t tests were used for statistical analysis. See Fig. S6
for additional data on SO and SP interneurons. (F and G) In situ hybridization with fluorescent probes against Gad1 and Gad2, V1aR, and V1bR mRNA
transcripts in the CA3 region of the P0 rat hippocampus (n = 5 brains). (F1) Gad1/2 mRNA black puncta label interneurons in all layers. (F2) V1aR mRNA is
predominantly expressed in the SLR. (F3) V1bR mRNA expression was not detected in the CA3 area. (F4) Merge of F1–3. (Scale bar: 50 μM.) (G) Confocal image
taken from the SLR. V1aR mRNA (green) localizes to a Gad1/2-positive cell (red). (Scale bar: 10 μm.) DAPI (purple) was used for nuclear staining. A positive
control of the V1bR mRNA probe is shown in Fig. S7.
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Distinct spontaneous sharp wave events (SPWs), similar to
those seen in mature rats and mice (32), were readily detected in
LFP recordings from hippocampal slices of P0–P2 guinea pigs
(Fig. 6C). In a manner similar to its action on fGDPs in the
hippocampal preparation from perinatal rats, 10 nM AVP pro-
duced a pronounced suppression of neonatal guinea pig SPWs,
which was prevented by SR49059 (20–30 nM) (Fig. 6D). In-
terneuronal activity is known to be crucial in shaping SPWs (32,
52, 53); hence, we examined whether the suppression of SPWs in
the neonatal guinea pig was attributable to interneuronal acti-
vation by AVP. In whole-cell voltage-clamp recordings from
CA3 pyramidal neurons, AVP induced a significant increase in
sIPSC frequency, similar to that seen in rats (Fig. 6E). In sum,
the present data demonstrate that AVP activates interneurons,
and thereby suppresses perinatal hippocampal network events,
regardless of whether the driving force for GABAAR-mediated
signaling is depolarizing or hyperpolarizing.
Discussion
The present study indicates that during birth, in parallel to pe-
ripheral AVP-mediated adaptive responses, such as those target-
ing the cardiorespiratory system (9), synergistic effects take place
in the brain. Our data show that AVP has a powerful suppressive
effect on perinatal hippocampal network events in species with
altricial (rat) as well as precocial (guinea pig) neonates. It is in-
deed remarkable that in both species, the desynchronizing effect
induced by AVP is similar, based on increased firing of inter-
neurons, with an outcome at the network level that is not de-
pendent on the stage of brain maturity at birth. We show that the
present neurophysiological effects of AVP are based on V1aR-
mediated signaling, which acts directly on neuronal network ac-
tivity in a manner that is expected to have neuroprotective effects,
as will be discussed below.
Tyzio et al. (40, 41) proposed a preemptively acting mechanism
based on the actions of maternally derived OT, acting on OTRs in
fetal hippocampal and neocortical pyramidal neurons to produce
a large transient negative shift in EGABA. In altricial species, a
negative shift in EGABA based on attenuation of secondary-active
Cl− uptake by NKCC1 would indeed be expected to reduce ac-
tivity on the single-cell level as well as the network level (54), and
consequently reduce the energy metabolic demand. However, our
data show that in the rat hippocampus, GABAAR agonists have
a constant depolarizing action on intact neurons from the late
fetal (E21.5) to early postnatal period. We also show here that
bumetanide-sensitive fGDPs were observed without exception in
the intact rat hippocampus preparation as well as in acute hip-
pocampal slices during the time window from E21.5 to postnatal
hour 2 (PNH2) and later, matching our electrophysiological and
imaging data on the depolarizing actions of perinatal GABA.
In numerous mammalian species, including humans, parturition
is accompanied by a massive release of AVP by the fetus itself
(reviewed in ref. 9). In the rat, AVP is detectable in the embryonic
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brain in its fully processed form already at E16 (55). In light of this,
we hypothesized that a mechanism endogenous to the fetal brain
could be an efficient strategy for neuroprotection during birth.
The idea that fetal AVP might have a neuromodulatory role
during mammalian birth is supported by evidence for vaso-
pressinergic innervation of the rat brain, including the hippo-
campus, already at late fetal stages (27). In agreement with
this, our structural data based on CLARITY show that vaso-
pressinergic innervation of the rat hippocampus is present at
P0. Our electrophysiological data show that AVP at 10 nM
suppressed fGDPs throughout the perinatal period, providing
functional evidence of the neuromodulatory role of AVP.
Notably, a shift in EGABA was not the underlying mechanism of
this suppression. Discrete events of synchronous network activity,
such as GDPs and SPWs (32, 56), exert a particularly high energy-
metabolic load on the brain due to the pronounced temporal
coincidence of GABAergic and glutamatergic inputs (34). Hence,
suppressing this synchronized activity would lead to a reduction of
energy demand, which is highly beneficial under compromised
conditions for oxygen supply, such as birth under normal, and es-
pecially pathophysiological, conditions, where intrapartum asphyxia
is a prime example. Gross desynchronization of temporally struc-
tured activity, such as, for example, the AVP-mediated effect shown
here, would be also very efficient to prevent the generation of
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“nonsense”Hebbian associative synaptic connections in response to
the extremely intense and unique sensory input that is associated
with birth. A case in point here is the demonstration that GDPs act
as coincidence detectors in the immature hippocampus to promote
the development of functional connectivity (57, 58). Clearly, such
an activity-dependent wiring mechanism would be blocked by AVP
at birth, thereby directly suppressing the formation of maladaptive
connectivity by birth-specific stimuli.
AVP is a potent modulator of interneurons and pyramidal neu-
rons in the mature rat hippocampal CA1 area (59–62); however,
comparable data from the developing hippocampus have not been
reported. We now show enriched expression of V1aR mRNA in
GABAergic interneurons in the CA3 region of the perinatal rat
hippocampus, which, together with our electrophysiological data,
suggests that interneurons are the main target of AVP in the
perinatal rat CA3 region. It is well known that interneurons are
important in the generation and shaping of network events and
oscillations in the brain (32, 52, 53). Thus, an AVP-induced increase
in the firing of hippocampal interneurons is expected to lead to the
desynchronization and consequent suppression of fGDPs, as indeed
was observed in the present study. With regard to the temporal
properties of AVP actions, in our in vitro preparations, both the
AVP-induced suppression of network events and the activation of
interneurons were transient in nature, most likely due to receptor
desensitization (45). When extrapolating these findings to in vivo
conditions, it should be noted that AVP release from vaso-
pressinergic fibers is triggered by bursts of action potentials
(63); therefore, the desensitization seen with bath-applied AVP
most likely has no counterpart in vivo.
The stage of brain development at birth shows enormous
species-specific variation (51, 64, 65). With respect to birth, the
timing of the developmental up-regulation of the main neuronal
Cl− extruder KCC2, and thus the shift from depolarizing to
hyperpolarizing postsynaptic GABAAR signaling, is a pertinent
example (30, 54, 66). We utilized the newborn guinea pig, a
precocial rodent, in which cortical development is at a stage
comparable to that of a 3-wk-old rat (65). The HPA axis and
GABAergic mechanisms involved in the shaping of spontaneous
network events are at a much more advanced level of develop-
ment in the newborn guinea pig (10, 30), which makes the pre-
sent comparisons between the rat and guinea pig uniquely
valuable in identifying evolutionarily conserved mechanisms of
mammalian neuroprotection at birth. In sharp contrast to rats,
neonatal guinea pig hippocampal pyramidal neurons have a high
capacity for KCC2-mediated Cl− extrusion, which readily ex-
plains their hyperpolarizing GABAAR responses (30). In line
with this, LFP recordings from neonatal guinea pig hippocampi
displayed prominent SPWs, which closely resembled those seen
in mature rats (32). As interneurons are essential in organizing
pyramidal cell activity during SPWs (32, 52, 53), tonic inter-
neuron spiking was expected to interfere with these network
events. Indeed, as seen in the rat, AVP also enhanced inter-
neuron firing in the guinea pig, which subsequently led to at-
tenuation of SPWs. The fact that the effects of AVP showed
basically similar characteristics in neonates of both the altricial
rat and precocial guinea pig suggests a pan-mammalian pro-
tective action of AVP during birth. This implies that the present
mechanism and conclusions are valid with regard to humans,
where birth takes place at a stage of brain maturity that is in-
termediate with regard to the two rodent species examined.
In conclusion, an inadequate supply of oxygen associated
with delivery under normal, and especially under pathophysi-
ological, conditions is a major threat to the fetal mammalian
brain. The obligatory period of asphyxia during the transition
from umbilical cord-mediated to lung-based exchange of oxy-
gen and carbon dioxide is known to be counteracted by hor-
monal and cardiovascular mechanisms leading to enhanced
brain perfusion (1, 9). Our work indicates that in the fetal brain,
AVP targets interneurons located in the hippocampus in a
V1aR-dependent manner, leading to suppression of neuronal
network activity, and thereby to a decrease in the activity-
dependent energy demand (34). Given the high and widely
recognized need for drugs that would protect the human ne-
onate brain under adverse conditions, such as perinatal asphyxia
(67), the present study may also open up avenues for the design
of novel drugs that act on the vasopressinergic system.
Materials and Methods
Animals.Wistar rats [E21.5–P2 (perinatal), P14–P16, and P60] and guinea pigs
(E34 ± 7 and P0–P2) of either sex were used for the study. PNH2 refers to rat
pups, which have been decapitated within 15–120 min after birth. For tar-
geted electrophysiological recordings from interneurons, VGAT-Venus
transgenic rat pups of either sex (P0–P2) were used (48). All experiments
carried out were approved by the National Animal Ethics Committee of
Finland and the Local Animal Ethics Committee of the University of Helsinki.
Hippocampal Preparations. The preparation of acute horizontal brain slices
(rat: 400–500 μm, guinea pig: 400–650 μm) and intact hippocampi (hippo-
campus in toto) was done as described previously (42, 68, 69). Details are
provided in Supporting Information. Neonatal guinea pigs were deeply
anesthetized with an i.p. injection of pentobarbital (∼70 mg/kg) and trans-
cardially perfused with ice-cold sucrose-based cutting solution before brain
dissection. For collection of embryos, timed pregnant rats and guinea pigs
were anesthetized (3–4% isoflurane), after which a cesarean section was
performed and embryonic brains were collected in ice-cold cutting solution.
Intracellular Ca2+ Imaging. Intracellular Ca2+ imaging was done from acute
hippocampal slices, which were loaded with Fluo-4-AM (Invitrogen/
MolecularProbes). GABAAR activation was done by bath application of muscimol
(5–10 μM; Tocris) or GABA (50–100 μM; Tocris) in the presence of TTX (1 μM,
upon muscimol application) or TTX/CGP55845 (1 μM and 0.5 μM, respectively,
upon GABA application). Details are provided in Supporting Information.
Electrophysiological Recordings. Electrophysiological recordings from acute
slices and in toto preparations were performed in a submerged recording
chamber at 32 ± 0.5 °C, constantly perfused with standard solution
(3.5 mL·min−1 or 5 mL·min−1, respectively) in which the concentration of
KCl was raised to 3.5–4 mM. Before recordings, preparations were equili-
brating in the recording chamber for 15 min. Depending on the experi-
ment, the following drugs were included in the extracellular solution:
D-AP5 and CNQX [20 μM and 10 μM, respectively; Tocris (referred to as
“iGluR block”)], TTX (0.5 μM; Tocris), picrotoxin (100 μM; Tocris), and
SR49059 (20–30 nM; Tocris).
LFP recordings were obtained with an EXT-02B amplifier (npi electronic
GmbH) or a custom-made amplifier, using thin-filament glass-capillary elec-
trodes with tip diameters of 5–10 μm, filled with 150 mM NaCl solution. The
electrodes were placed in SP of the hippocampal CA3 area. Experiments
were recorded to disk with WinEDR (Strathclyde Electrophysiology) using
1,000× gain and low-pass filtering at 1,000–5,000 Hz.
Whole-cell voltage-clamp and current-clamp recordings were obtained
using an EPC 10 patch-clamp amplifier (HEKA) and recorded with Patch-
master (HEKA) at a sampling rate of 20–50 kHz. Borosilicate patch pipette
resistance ranged from 3 to 8 MΩ. All cells included in the analyses had a
resting membrane potential below −55 mV and a stable holding current.
Series resistance compensation was performed online. Recordings in which
the series resistance changed >25% or reached 25 MΩ were not included in
the analysis. All voltages have been corrected for the respective liquid
junction potential (LJP).
For CA3 pyramidal neuron excitability recordings in the loose cell-attached
configuration, patch pipettes were filled with standard solution. Isoguvacine
(100 μM, in standard solution) was puff-applied (50-ms puff duration) every
30 s from a glass capillary positioned over the slice, with the tip close to the
soma of the recorded cell. The extracellular solution was supplemented with
iGluR block throughout the recordings.
For whole-cell voltage-clamp recordings of IPSCs and EPSCs, the patch pi-
pettes were filled with the following solution: 140 mM Cs-methanesulfonate,
2 mM MgCl2, and 10 mM Hepes [with pH adjusted to 7.2 with CsOH (280 ±
5 mOsm), 13-mV calculated LJP]. For IPSC recordings, neurons were held at a
holding potential of 0 mV (approximate equilibrium potential of glutamate
receptor-mediated currents) and iGluR blockers were added to the extracel-
lular solution when indicated. For mIPSC recordings, the extracellular solution
was further supplemented with TTX. Due to high sIPSC frequencies in guinea pig
E10826 | www.pnas.org/cgi/doi/10.1073/pnas.1717337114 Spoljaric et al.
pyramidal neurons, only those recordings with a baseline sIPSC frequency below
25 Hz were analyzed. For EPSC recordings, neurons were held at a holding po-
tential of −70 mV and picrotoxin was added to the extracellular solution.
For whole-cell current-clamp recordings (I = 0 pA) of spiking and mem-
brane potential in pyramidal neurons and interneurons, the extracellular
solution was supplemented with iGluR blockers and picrotoxin where in-
dicated. Patch pipettes were filled with the following solution: 29 mM KCl,
101 mM K-gluconate, 0.5 mM CaCl2, 5 mM 1,2-bis(2-aminophenoxy)ethane-
N,N,N′,N′-tetraacetic acid (BAPTA), 10 mM Hepes, 10 mM glucose, 2 mMMg-
ATP, and 2 mM NaOH [with pH adjusted to 7.3 with KOH (280 ± 5 mOsm),
and calculated LJP of 14 mV].
For quantitative assessment of neuronal Cl− extrusion capacity, we used
our standard assay, where a constant somatic Cl− load (19 mM) is imposed on
the neuron via a whole-cell patch pipette (70, 71). Details are provided in
Supporting Information.
Analysis of Electrophysiological Recordings. The analysis of electrophysio-
logical recordings was done with Clampfit (version 10.5; Axon). All clearly
distinguishable fGDPs and GDP-associated sIPSC bursts were manually de-
tected, and the area (megavolt × millisecond), which takes into account
changes in both event amplitude and duration, was quantified using nu-
merical integration in Clampfit for each event. Guinea pig SPWs were de-
tected manually, using a threshold of 3× SD baseline noise. The event areas
were assigned to 10-s bins according to the temporal occurrence of the
events to obtain the total area for each bin. The data were normalized and
presented as a moving average (60-s window, 10-s bins, 10-s step). IPSCs and
sEPSCs were analyzed with Mini Analysis (Synaptosoft) using a threshold of
three to four × baseline rms noise.
RNAscope in Situ Hybridization Assay. The detection of mRNA by RNAscope
(Advanced Cell Diagnostics) was done according to the manual. Details are
provided in Supporting Information. Specific probes to detect Gad1 (316401-
C2), Gad2 (435801-C2), V1a (402531-C3), and V1b (443831) mRNA transcripts
were designed and provided by Advanced Cell Diagnostics.
Western Blot. KCC2 protein levels in rat and guinea pig hippocampi were
analyzed by Western blotting as described previously (72). Details are pro-
vided in Supporting Information.
CLARITY. CLARITY tissue was prepared as described by Tomer et al. (35), with
minor modifications. Details are provided in Supporting Information.
Statistical Analysis. Independent or paired t tests were used to determine
statistically significant differences between groups. All values are presented
as mean ± SEM. Statistical significance was defined as P < 0.05. The effect of
bath-applied neurohormones (AVP/OT) was quantified as the average within
a 2-min time window starting 2 min after the beginning of application. The
analysis was performed using IMB SPSS statistics 22.
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